Citius Oncology (CTOR) Institutional Ownership $0.65 -0.03 (-4.54%) As of 11:23 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Citius Oncology (NASDAQ:CTOR)CurrentInstitutional OwnershipPercentage70.52%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$42.30KNumber ofInstitutional Sellers(last 12 months)0 Get CTOR Insider Trade Alerts Want to know when executives and insiders are buying or selling Citius Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Remove Ads Citius Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Citadel Advisors LLC22,699$26K0.0%N/A0.032% 2/4/2025IFP Advisors Inc22,215$26K0.0%+173.1%0.031% (Data available from 1/1/2016 forward)Remove Ads CTOR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CTOR shares? During the previous two years, the following institutional investors and hedge funds held shares of Citius Oncology shares: Citadel Advisors LLC ($26K), IFP Advisors Inc ($26K).Learn more on CTOR's institutional investors. What percentage of Citius Oncology stock is owned by institutional investors? 70.52% of Citius Oncology stock is owned by institutional investors. Learn more on CTOR's institutional investor holdings. Which institutional investors have been buying Citius Oncology stock? The following institutional investors have purchased Citius Oncology stock in the last 24 months: Citadel Advisors LLC ($22.70K), and IFP Advisors Inc ($14.08K). How much institutional buying is happening at Citius Oncology? Institutional investors have bought a total of 36,779 shares in the last 24 months. This purchase volume represents approximately $42.30K in transactions. Related Companies SOPHiA GENETICS Institutional Ownership Protalix BioTherapeutics Institutional Ownership Terns Pharmaceuticals Institutional Ownership Cardiff Oncology Institutional Ownership Gossamer Bio Institutional Ownership Tevogen Bio Institutional Ownership TuHURA Biosciences Institutional Ownership MediWound Institutional Ownership LifeVantage Institutional Ownership Voyager Therapeutics Institutional Ownership This page (NASDAQ:CTOR) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Citius Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Citius Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
